Daily News Podcast

Bempedoic acid: funny name, serious LDL lowering

Publish date: March 15, 2019

 

Bempedoic acid safely dropped LDL cholesterol, and now it’s up for FDA approval. Recent trials advance axial spondyloarthritis therapy. Newer antihyperglycemic drugs have distinctive cardiovascular, kidney benefits. And doctors’ prior authorization burden is increasing.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Recommended Reading

Trump targets abortion by denying family planning funds
MDedge Hematology and Oncology
Caring for aging HIV-infected patients requires close attention to unrelated diseases
MDedge Hematology and Oncology
Will having fewer primary care physicians shorten Americans’ lifespans?
MDedge Hematology and Oncology
Cancer-battling breath, Zombie Bambi, and hops as health food
MDedge Hematology and Oncology
Esketamine gets the green light for depression
MDedge Hematology and Oncology
Ready for universal hepatitis C testing?
MDedge Hematology and Oncology
Autism risk with in utero infections
MDedge Hematology and Oncology
Aspirin and lower risk of COPD flare-up
MDedge Hematology and Oncology
Treating lymphoma in patients with HIV
MDedge Hematology and Oncology
Semaglutide plus SGLT2 inhibitors for type 2 diabetes
MDedge Hematology and Oncology